Comparison of pre- and intrapartum screening of group B streptococci and adherence to screening guidelines: a cohort

Mirjam Kunze1, Katharina Zumstein, Filiz Markfeld-Erol

  • 1Department of Gynecology and Obstetrics, University Medical Center Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany, mirjam.kunze@uniklinik-freiburg.de.

Insights

Prepartum screening for group B Streptococcus (GBS) is effective in predicting intrapartum colonization, though improved adoption strategies are necessary. This study evaluated GBS screening methods in pregnant women, finding similar colonization rates between prepartum and intrapartum screenings.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Microbiology

Background:

  • Group B Streptococcus (GBS) prepartum screening (PS) evaluation is limited.
  • Predictive value of PS for intrapartum colonization requires further study.
  • Longitudinal GBS screening data is crucial for program evaluation and vaccine development.

Purpose of the Study:

  • To assess prepartum GBS screening (PS) at 35-37 weeks gestation.
  • To compare the predictive value of PS versus intrapartum screening (IS).
  • To evaluate intrapartum antibiotic prophylaxis (IAP) rates and GBS transmission to neonates.

Main Methods:

  • A surveillance cohort study of 937 pregnant women at a tertiary care center.
  • Comparison of GBS colonization status from PS and IS.
  • Calculation of positive predictive value and IAP rates.
  • Neonatal GBS transmission assessment via cultures.

Main Results:

  • 67.5% of women had PS, with only 22.7% adhering to guidelines.
  • Maternal GBS colonization rates were similar: PS (18.5%) vs. IS (17.0%).
  • Positive predictive value of PS for intrapartum GBS positivity was 77.2%.
  • 89.3% of women with positive PS received IAP.
  • GBS serotype distribution remained stable compared to a 2003-2004 study.

Conclusions:

  • Improved strategies for prepartum GBS screening adoption are needed.
  • Prepartum GBS screening accurately predicts intrapartum colonization.
  • Stable serotype distribution suggests potential long-term efficacy of GBS vaccines.
Abstract